Research ArticleIMMUNOTHERAPY

Targeting monoamine oxidase A for T cell–based cancer immunotherapy

See allHide authors and affiliations

Science Immunology  14 May 2021:
Vol. 6, Issue 59, eabh2383
DOI: 10.1126/sciimmunol.abh2383

Article Information

vol. 6 no. 59

PubMed: 
Published By: 
History: 
  • Received February 24, 2021
  • Accepted April 15, 2021
  • .

Author Information

  1. Xi Wang1,
  2. Bo Li1,
  3. Yu Jeong Kim1,
  4. Yu-Chen Wang1,
  5. Zhe Li1,
  6. Jiaji Yu1,
  7. Samuel Zeng1,
  8. Xiaoya Ma1,
  9. In Young Choi1,
  10. Stefano Di Biase1,
  11. Drake J. Smith1,
  12. Yang Zhou1,
  13. Yan-Ruide Li1,
  14. Feiyang Ma2,
  15. Jie Huang1,
  16. Nicole Clarke1,
  17. Angela To1,
  18. Laura Gong1,
  19. Alexander T. Pham1,
  20. Heesung Moon1,
  21. Matteo Pellegrini2,3 and
  22. Lili Yang1,4,5,6,*
  1. 1Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, CA 90095, USA.
  2. 2Department of Molecular, Cell and Developmental Biology, University of California, Los Angeles, CA 90095, USA.
  3. 3Institute for Genomics and Proteomics, University of California, Los Angeles, CA 90095, USA.
  4. 4Molecular Biology Institute, University of California, Los Angeles, CA 90095, USA.
  5. 5Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California, Los Angeles, CA 90095, USA.
  6. 6Jonsson Comprehensive Cancer Center, the David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.
  1. *Corresponding author. Email: liliyang{at}ucla.edu

Altmetric

Article usage

Article usage: May 2021 to July 2021

AbstractFullPdf
May 2021150321100557
Jun 20213644364241
Jul 2021105711993

Stay Connected to Science Immunology